ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 131 filers reported holding ACCELERON PHARMA INC in Q2 2017. The put-call ratio across all filers is 4.16 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $431,000 | -29.0% | 8,892 | -42.7% | 0.10% | +3.0% |
| Q1 2018 | $607,000 | -11.8% | 15,531 | -4.2% | 0.10% | -19.4% |
| Q4 2017 | $688,000 | +11.7% | 16,212 | -1.9% | 0.12% | +8.8% |
| Q3 2017 | $616,000 | -15.0% | 16,521 | -30.8% | 0.11% | -27.8% |
| Q2 2017 | $725,000 | +14.7% | 23,878 | 0.0% | 0.16% | +32.8% |
| Q1 2017 | $632,000 | -6.6% | 23,878 | -10.1% | 0.12% | -7.8% |
| Q4 2016 | $677,000 | -81.7% | 26,565 | -75.5% | 0.13% | -66.1% |
| Q3 2016 | $3,691,000 | -11.7% | 108,632 | -11.7% | 0.38% | +5.2% |
| Q2 2016 | $4,181,000 | +25.0% | 123,065 | -2.9% | 0.36% | +46.6% |
| Q1 2016 | $3,344,000 | +19.7% | 126,726 | +56.1% | 0.25% | +384.3% |
| Q4 2015 | $2,794,000 | – | 81,176 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 1,400,000 | $133,378,000 | 3.73% |
| Foresite Capital Management III, LLC | 42,030 | $4,004,000 | 3.56% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 257,249 | $24,508,000 | 2.23% |
| Cormorant Asset Management, LP | 600,000 | $57,162,000 | 2.18% |
| Avoro Capital Advisors LLC | 1,040,000 | $99,081,000 | 1.96% |
| QVT Financial LP | 101,396 | $9,660,000 | 1.64% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,100,000 | $200,067,000 | 1.60% |
| Rhenman & Partners Asset Management AB | 155,000 | $14,767,000 | 1.60% |
| Parkman Healthcare Partners LLC | 57,500 | $5,478,000 | 1.54% |
| Ikarian Capital, LLC | 187,700 | $17,882,000 | 1.42% |